Re: Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer

被引：0
|
作者：
不详
机构：
来源：
JOURNAL OF UROLOGY | 2021年 / 205卷 / 01期
关键词：
D O I：
10.1097/JU.0000000000001450
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：303 / 304
页数：2
相关论文
共 50 条
  • [21] Next-generation Sequencing of Advanced Prostate Cancer Treated with Androgen-deprivation Therapy
    Rajan, Prabhakar
    Sudbery, Ian M.
    Villasevil, M. Eugenia M.
    Mui, Ernest
    Fleming, Janis
    Davis, Mark
    Ahmad, Imran
    Edwards, Joanne
    Sansom, Owen J.
    Sims, David
    Ponting, Chris P.
    Heger, Andreas
    McMenemin, Rhona M.
    Pedley, Ian D.
    Leung, Hing Y.
    EUROPEAN UROLOGY, 2014, 66 (01) : 32 - 39
  • [22] Effectiveness of Androgen-Deprivation Therapy and Radiotherapy for Older Men With Locally Advanced Prostate Cancer
    Bekelman, Justin E.
    Mitra, Nandita
    Handorf, Elizabeth A.
    Uzzo, Robert G.
    Hahn, Stephen A.
    Polsky, Daniel
    Armstrong, Katrina
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07) : 716 - 722
  • [23] Final Report of the Intergroup Randomized Study of Combined Androgen-Deprivation Therapy Plus Radiotherapy Versus Androgen-Deprivation Therapy Alone in Locally Advanced Prostate Cancer
    Mason, Malcolm D.
    Parulekar, Wendy R.
    Sydes, Matthew R.
    Brundage, Michael
    Kirkbride, Peter
    Gospodarowicz, Mary
    Cowan, Richard
    Kostashuk, Edmund C.
    Anderson, John
    Swanson, Gregory
    Parmar, Mahesh K. B.
    Hayter, Charles
    Jovic, Gordana
    Hiltz, Andrea
    Hetherington, John
    Sathya, Jinka
    Barber, James B. P.
    McKenzie, Michael
    El-Sharkawi, Salah
    Souhami, Luis
    Hardman, P. D. John
    Chen, Bingshu E.
    Warde, Padraig
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (19) : 2143 - U170
  • [24] Adverse effects of androgen-deprivation therapy in prostate cancer and their management
    Rhee, Handoo
    Gunter, Jennifer H.
    Heathcote, Peter
    Ho, Ken
    Stricker, Phillip
    Corcoran, Niall M.
    Nelson, Colleen C.
    BJU INTERNATIONAL, 2015, 115 : 3 - 13
  • [25] Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer
    Smith, Matthew R.
    Egerdie, Blair
    Toriz, Narciso Hernandez
    Feldman, Robert
    Tammela, Teuvo L. J.
    Saad, Fred
    Heracek, Jiri
    Szwedowski, Maciej
    Ke, Chunlei
    Kupic, Amy
    Leder, Benjamin Z.
    Goessl, Carsten
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (08): : 745 - 755
  • [26] Metabolic and cardiovascular risks of androgen-deprivation therapy for prostate cancer
    Nambudiri, Vinod E.
    Keating, Nancy L.
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2010, 5 (04) : 531 - 537
  • [27] Androgen-Deprivation Therapy and the Risk of Stroke in Patients With Prostate Cancer
    Azoulay, Laurent
    Yin, Hui
    Benayoun, Serge
    Renoux, Christel
    Boivin, Jean-Francois
    Suissa, Samy
    EUROPEAN UROLOGY, 2011, 60 (06) : 1244 - 1250
  • [28] Reimbursement Policy and Androgen-Deprivation Therapy for Prostate Cancer.
    Shahinian, Vahakn B.
    Kuo, Yong-Fang
    Gilbert, Scott M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (19): : 1822 - 1832
  • [29] Testosterone suppression and recovery in patients with advanced prostate cancer treated with intermittent androgen deprivation therapy with relugolix
    Campbell, Patrick
    Gebrael, Georges
    Narang, Arshit
    Chehade, Chadi Hage
    Thomas, Vinay Mathew
    Fortuna, Gliceida Galarza
    Sayegh, Nicolas
    Tripathi, Nishita
    Tandar, Clara
    Dal, Emre
    Li, Haoran
    Swami, Umang
    Agarwal, Neeraj
    Maughan, Benjamin L.
    THERAPEUTIC ADVANCES IN UROLOGY, 2024, 16
  • [30] Androgen-Deprivation Therapy and Metabolic Syndrome in Men With Prostate Cancer
    Harrington, Joanne M.
    Schwenke, Dawn C.
    Epstein, Dana R.
    Bailey, Donald E., Jr.
    ONCOLOGY NURSING FORUM, 2014, 41 (01) : 21 - 29
12345